Cover Image
市場調查報告書

SEEK Group:產品平台分析

SEEK Group - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 341859
出版日期 內容資訊 英文 39 Pages
訂單完成後即時交付
價格
Back to Top
SEEK Group:產品平台分析 SEEK Group - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 39 Pages
簡介

SEEK Group 是開發感染疾病預防及治療的疫苗的製藥公司。該公司提供咳嗽、感冒、發炎性痛覺新的預防治療方法、自體免疫疾病及癌症的治療方法,以及,也開發B型及C型肝炎、流感、HIV、輪狀病毒感染疾病的合成/T細胞疫苗。

本報告提供SEEK Group 的治療藥開發平台的現狀及各開發階段比較分析、藥物標的、作用機制、給藥途徑、各分子類型的治療藥的評估及暫停中的計劃相關資訊等

SEEK Group的基本資料

  • SEEK Group概要
  • 主要資訊
  • 企業資料

SEEK Group:R&D概要

  • 主要的治療範圍

SEEK Group:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

SEEK Group:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

SEEK Group:藥物簡介

SEEK Group:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

SEEK Group:最近的開發平台趨勢

SEEK Group:暫停中的計劃

SEEK Group:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC07262CDB

Summary

Global Markets Direct's, 'Seek Group - Product Pipeline Review - 2015', provides an overview of the Seek Group's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Seek Group's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Seek Group including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Seek Group's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Seek Group's pipeline products

Reasons to buy

  • Evaluate Seek Group's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Seek Group in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Seek Group's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Seek Group and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Seek Group
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Seek Group and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • SEEK Group Snapshot
    • SEEK Group Overview
    • Key Information
    • Key Facts
  • SEEK Group - Research and Development Overview
    • Key Therapeutic Areas
  • SEEK Group - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • SEEK Group - Pipeline Products Glance
    • SEEK Group - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • SEEK Group - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • SEEK Group - Drug Profiles
    • Flu-v
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HIV vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • chagas disease vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Breast Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Lung Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Prostate Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hepatitis B vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hepatitis C vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • malaria vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • rotavirus vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Monoclonal Antibody for Chagas
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Monoclonal Antibody for Hepatitis B
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Monoclonal Antibody for Hepatitis C
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Monoclonal Antibody for Malaria
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Monoclonal Antibody for Tuberculosis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Monoclonal Antibody to Inhibit Virion Infectivity Factor for HIV
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • SEEK Group - Pipeline Analysis
    • SEEK Group - Pipeline Products by Target
    • SEEK Group - Pipeline Products by Route of Administration
    • SEEK Group - Pipeline Products by Molecule Type
    • SEEK Group - Pipeline Products by Mechanism of Action
  • SEEK Group - Recent Pipeline Updates
  • SEEK Group - Dormant Projects
  • SEEK Group - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • SEEK Group, Key Information
  • SEEK Group, Key Facts
  • SEEK Group - Pipeline by Indication, 2015
  • SEEK Group - Pipeline by Stage of Development, 2015
  • SEEK Group - Monotherapy Products in Pipeline, 2015
  • SEEK Group - Phase II, 2015
  • SEEK Group - Preclinical, 2015
  • SEEK Group - Discovery, 2015
  • SEEK Group - Pipeline by Target, 2015
  • SEEK Group - Pipeline by Route of Administration, 2015
  • SEEK Group - Pipeline by Molecule Type, 2015
  • SEEK Group - Pipeline Products by Mechanism of Action, 2015
  • SEEK Group - Recent Pipeline Updates, 2015
  • SEEK Group - Dormant Developmental Projects,2015
  • SEEK Group, Other Locations

List of Figures

  • SEEK Group - Pipeline by Top 10 Indication, 2015
  • SEEK Group - Pipeline by Stage of Development, 2015
  • SEEK Group - Monotherapy Products in Pipeline, 2015
  • SEEK Group - Pipeline by Top 10 Target, 2015
  • SEEK Group - Pipeline by Top 10 Molecule Type, 2015
  • SEEK Group - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top